Pipeline
A series of world-leading natural TIL and genetically modified TIL therapies has been developed by virtue of the DeepTIL®cell expansion platform and the NovaGMP®gene modification platform.
Pipeline
Natural TIL
GC101
Genetically modified TIL
GC201
GC202
GC203
GC204
Indications
Pre-clinical
IIT
Pre-IND
Phase Ⅰ
Phase Ⅱ/Ⅲ
BLA
NDA
Advanced solid tumor
Advanced solid tumor
Advanced solid tumor
Advanced solid tumor
Advanced solid tumor